Treatment of multiple sclerosis: role of natalizumab

被引：20

作者：

Comi, Giancarlo ^{[1
]}

机构：

[1] Univ Vita Salute San Raffaele, San Raffaele Sci Inst, Inst Expt Neurol, Dept Neurol, I-20132 Milan, Italy

来源：

NEUROLOGICAL SCIENCES | 2009年 / 30卷

关键词：

Interferon-beta; Glatiramer acetate; Mitoxantrone; Natalizumab; PLACEBO-CONTROLLED TRIAL; MITOXANTRONE-INDUCED CARDIOTOXICITY; DOUBLE-BLIND; INTERFERON BETA-1B; MAGNETIC-RESONANCE; GLATIRAMER ACETATE; ACUTE-LEUKEMIA; MULTICENTER; THERAPY; MS;

D O I：

10.1007/s10072-009-0147-2

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

100204 [神经病学];

摘要：

The results on relapse rate and disease progression of available drugs for multiple sclerosis are shown, as well as their most relevant side effects. Results from pivotal and long-term follw-up studies support the efficacy and safety of intererons and glatiramer acetate. The treatment with mitoxantrone is limited by the occurrence of infertility, cardiotoxicy and leukaemia. Efficacy and tolerability of natalizumab are undisputable, compared to other drugs. Risks related to its treatment are PML, opportunistic infections, hepatotoxicity, melanoma, and their occurrence needs to be more exactly assessed by post-marketing surveillance. The principles of induction versus escalating therapy are also discussed. The final therapeutic decision is based on the evaluation of the disease state and prognosis, based on clinical and instrumental measures, and on the safety/efficacy profile of each treatment.

引用

页码：155 / 158

页数：4

共 39 条

[1]

Rapid onset Mitoxantrone-induced cardiotoxicity in secondary progressive multiple sclerosis [J].

Avasarala, JR ;

Cross, AH ;

Clifford, DB ;

Singer, BA ;

Siegel, BA ;

Abbey, EE .

MULTIPLE SCLEROSIS, 2003, 9 (01) :59-62

[2]

European/Canadian multicenter, double-blind, randomized, placebo-controlled study of the effects of glatiramer acetate on magnetic resonance imaging-measured disease activity and burden in patients with relapsing multiple sclerosis [J].

Comi, G ;

Filippi, M ;

Wolinsky, JS .

ANNALS OF NEUROLOGY, 2001, 49 (03) :290-297

[3]

DUQUETTE P, 1995, NEUROLOGY, V45, P1277

[4]

INTERFERON BETA-1B IS EFFECTIVE IN RELAPSING-REMITTING MULTIPLE-SCLEROSIS - CLINICAL-RESULTS OF A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL [J].

DUQUETTE, P ;

GIRARD, M ;

DESPAULT, L ;

DUBOIS, R ;

KNOBLER, RL ;

LUBLIN, FD ;

KELLEY, L ;

FRANCIS, GS ;

LAPIERRE, Y ;

ANTEL, J ;

FREEDMAN, M ;

HUM, S ;

GREENSTEIN, JI ;

MISHRA, B ;

MULDOON, J ;

WHITAKER, JN ;

EVANS, BK ;

LAYTON, B ;

SIBLEY, WA ;

LAGUNA, J ;

KRIKAWA, J ;

PATY, DW ;

OGER, JJ ;

KASTRUKOFF, LF ;

MOORE, GRW ;

HASHIMOTO, SA ;

MORRISON, W ;

NELSON, J ;

GOODIN, DS ;

MASSA, SM ;

GUTTERIDGE, E ;

ARNASON, BGW ;

NORONHA, A ;

REDER, AT ;

MARTIA, R ;

EBERS, GC ;

RICE, GPA ;

LESAUX, J ;

JOHNSON, KP ;

PANITCH, HS ;

BEVER, CT ;

CONWAY, K ;

WALLENBERG, JC ;

BEDELL, L ;

VANDENNOORT, S ;

WEINSHENKER, B ;

WEISS, W ;

REINGOLD, S ;

PACHNER, A ;

TAYLOR, W .

NEUROLOGY, 1993, 43 (04) :655-661

[5]

Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosis [J].

Ebers, GC ;

Rice, G ;

Lesaux, J ;

Paty, D ;

Oger, J ;

Li, DKB ;

Beall, S ;

Devonshire, V ;

Hashimoto, S ;

Hooge, J ;

Kastrukoff, L ;

Krieger, C ;

Mezei, M ;

Seland, P ;

Vorobeychi, G ;

Morrison, W ;

Nelson, J ;

Freedman, MS ;

Chrisie, S ;

Nelson, R ;

Rabinovitch, H ;

Freedman, C ;

Hartung, HP ;

Rieckmann, P ;

Archelos, J ;

Jung, S ;

Weilbach, F ;

Flachenecke, P ;

Sauer, J ;

Hommes, O ;

Jongen, P ;

Brouwer, S ;

McLeod, J ;

Pollard, J ;

Ng, R ;

Sandberg-Wollheim, M ;

Källén, K ;

Nilsson, P ;

Ekberg, R ;

Lundgren, A ;

Jadbäck, G ;

Wikström, J ;

Multanen, J ;

Valjakka, M ;

Carton, H ;

Lissoir, F ;

Declerq, I ;

Vieren, M ;

Peeters, E ;

Dubois, B .

LANCET, 1998, 352 (9139) :1498-1504

[6]

EDAN G, 1995, NEUROLOGY S2, V242, pS38

[7]

Ellis, R. ;

Boggild, M. .

MULTIPLE SCLEROSIS JOURNAL, 2009, 15 (04) :505-508

[8]

*EMEA PRESS, 2008, HEP LOND 20 MARCH 20

[9]

*EUR MED AG, 2005, REB EUR PUBL ASS REP

[10]

Interferons in relapsing remitting multiple sclerosis: a systematic review [J].

Filippini, G ;

Munari, L ;

Incorvaia, B ;

Ebers, GC ;

Polman, C ;

D'Amico, R ;

Rice, GPA .

LANCET, 2003, 361 (9357) :545-552

← 1 2 3 4 →